Newly identified drug targets could open door for esophageal cancer therapeutics: Researchers block two cancer cell signaling pathways and slow tumor growth
Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal
Read more